Anesthetic and anti-inflammatory medication :: The total survey results of 2023 by the integrated assestment

The total survey results of 2023 by the integrated assestment in category

Cold and Flu / Anesthetic and anti-inflammatory medication

Integrated, “absolute” ratings is calculated by survey results of 3 respondent groups.

	Consumers (40%)
	Experts (40%)
	Celebrities (20%)

The Favorites of the Year is determined by the Consumers (non-indifferent public), Experts (authoritative specialists of this market industry) and Celebrities Jury (known public figures and celebrities).

In forming of the integrated ratings, the following weight is assumed:

Absolute rank = (average yearly rank of Consumers × 0.4) + (rank of Experts × 0.4) + (rank of Celebrities × 0.2).

1.		Ibuprofen-Darnitsa (Darnitsa)	5

2.	3	Ацетилсаліцилова кислота-Дарниця (Darnitsa)	4.76

3.	2	Цитрамон-Дарниця (Darnitsa)	4.29

4.	1	Аскофен-Дарниця (Darnitsa)	4.05

4.	2	Аспірин (Bayer)	4.05

6.	1	Аскофен Л (Лубнифарм)	3.33

–.		Baralgin (Алекс Фарм)	0

–.		Ibuprom (Delta Medical)	0

–.		Solpadeine (GlaxoSmithKline)	0

–.		Tempalgin (Sopharma)	0

–.		Ібупрофен (Борщагівський ХФЗ)	0

–.		Імет (Berlin-Chemie Menarini)	0

–.		Анальгин - Тернофарм (Ternopharm)	0

–.	4	Анальгін (Pharmaceutical company “Zdorovya”)	0

–.		Анальгін (Лубнифарм)	0

–.	4	Анальгін супозиторії (Nizhpharm)	0

–.	2	Анальгін-Дарниця (Darnitsa)	0

–.	1	Аскопар (Pharmaceutical company “Zdorovya”)	0

–.		Ацетилсаліцилова кислота (Arterium Corporation)	0

–.		Баралгетас (Jugoremedija)	0

–.		Бесалол (Pharmaceutical company “Zdorovya”)	0

–.		Бофен (Борщагівський ХФЗ)	0

–.		Брустан (Ranbaxy)	0

–.		Вобензим (Mucos Pharma)	0

–.		Вібуркол (Heel)	0

–.		Газоспазам (Kusum Pharm)	0

–.		Гофен (Mega Lifesciences)	0

–.		Грипго (Gledpharm)	0

–.		Долар (Rainbow)	0

–.		Дротаверин (Red star)	0

–.		Ефералган (Bristol-Myers Squibb)	0

–.		Зотек (ORGANOSYN)	0

–.		Комбіспазм (ORGANOSYN)	0

–.		Копацил (Arterium Corporation)	0

–.		Кофальгін (Борщагівський ХФЗ)	0

–.		Кофан (Bosnalijek)	0

–.		Мефенамінова кислота-Дарниця (Darnitsa)	0

–.		Налгезін (KRKA)	0

–.		Но-Х-ша (Лекхім)	0

–.	4	Но-Шпа (Sanofi)	0

–.		Нурофєн (Reckitt Benckiser)	0

–.	4	Німесил (Berlin-Chemie Menarini)	0

–.		Олфен (Teva)	0

–.		Панадол (GlaxoSmithKline)	0

–.		Папаверина гідрохлорид (Nizhpharm)	0

–.	4	Парацетамол (Arterium Corporation)	0

–.		Парацетамол (Лубнифарм)	0

–.		Парацетамол-Дарниця (Darnitsa)	0

–.		Пенталгін IC (InterChem)	0

–.		Пенталгін-ICN (Фармстандарт-Лекарства)	0

–.		Пенталгін-ФС (Фарма Старт)	0

–.		Пиарон (Kusum Pharm)	0

–.		Промакс (Hikma)	0

–.		П’ятирчатка IC (InterChem)	0

–.		Раптен (Hemofarm)	0

–.		Рапідол (Actavis)	0

–.		Ріабал (Hikma)	0

–.		Седалгін Нео (Actavis)	0

–.		Спазмалгон (Actavis)	0

–.		Тайлолфен Хот (Нобель Ілач)	0

–.		Таміпул (Pro-Pharma)	0

–.		Тилда (Genom Biotech)	0

–.		Тринелл (Береш Фарма)	0

–.		Упсарин Упса (Bristol-Myers Squibb)	0

–.		Фармадол (Farmak)	0

–.		Флогензим (Mucos Pharma)	0

–.		Цефекон Н (Nizhpharm)	0

–.		Цитрамон Екстра (Darnitsa)	0

–.		Цитрамон У (Лубнифарм)	0

–.		Цитрамон-М (Red star)	0

–.		Цитрамон-Ф (Фітофарм)	0

–.		Цитропак–Дарниця (Darnitsa)	0

The participant which took the 1st place in this rating is by aggregate opinion of all three respondent groups is the best choice in 2023, the absolute recommendation of #1 in the category “Anesthetic and anti-inflammatory medication”.

Using this rating is only possible with obligatory link to the source.

This rating was built as a result of the study of social preferences in 2023, under the “Favorites of Success” Contest in Ukraine and it’s the free information. In case of full or partial republishing of the information drawn from this rating, it is obligatory to mention the name of the “Favorites of Success” Contest in printed publications, or put an active hyperlink to this page in the electronic media. “Favorite of Success” medal

Participants of the contest (not excluding the leader) can also freely use this information in their news, press releases, reports and other PR-communications. However, it should be understood that the image of the contest awards, such like “Favorite of Success – 2023” medal, which is awarded to the winners at the annual awards ceremony, as well as official winner status &mdashl is the registered Trademarks, and their use requires permission, license.

Leader of this rating has an opportunity to get benefits of the rights and privileges of winner, the “Absolute Favorite”. The winner may be represented in the status of the best choice in the category “Anesthetic and anti-inflammatory medication”, and receive an award, a gold medal “Favorite of Success – 2023”, on an annual awards ceremony, along with the right to use its image in the advertising and labeling.